Booz Allen CTO Bill Vass explains why the firm recently joined the Alliance for OpenUSD and its plans for a 3D repository. An ...

Good morning, ladies and gentlemen, and welcome to Veradermic's conference call to discuss results from the female trial arms of Study 207, a Phase II open-label trial evaluating VDPHL01 for mild to ...